Help protect the moments that matter with a first-of-its-kind targeted NSAID for canine osteoarthritis pain and inflammation.
If your dog can't climb the stairs, who will check under the bed for monsters? Canine osteoarthritis pain can steal moments like these from your best friend. Protect the joy with Galliprant, a first-of-its-kind NSAID that treats canine osteoarthritis pain and inflammation.
Innovative treatment
Safe to use daily
Targeted
Why allow canine osteoarthritis pain to ruin special moments with your dog? Talk to your veterinarian about taking action with Galliprant.
Galliprant is a first-of-its-kind NSAID that targets the source of osteoarthritis pain and inflammation while reducing the impact on kidney and liver health.ǂ
Targets the source of canine osteoarthritis pain and inflammation
Flavored, chewable tablet that's safe to use daily
Treats canine osteoarthritis pain and inflammation early on,* and can be used as long as neededǂ
ǂ Monitoring is recommended if used long-term.
* Approved for use in dogs older than 9 months of age and greater than 8 pounds.
Every day, there are special moments you share with your dog – and you don't want canine osteoarthritis pain interrupting them. Learn about why Galliprant could be a good choice to help treat your dog's osteoarthritis pain and inflammation.
Canine osteoarthritis can keep your dog from being active and by your side. Learn about the disease and how treatment with Galliprant can help at any stage.*
* Approved for use in dogs older than 9 months of age and greater than 8 pounds.
Over 65 years of experience
Global presence in 90 countries
At Elanco, we provide those who raise and care for animals with solutions that empower them to advance a vision of food and companionship enriching life.
Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.
Not for use in humans. Keep out of reach of children and pets. Monitoring is recommended if used long term. Should not be used in dogs who are allergic to grapiprant or with other anti-inflammatory drugs. The safe use of Galliprant has not been studied in dogs younger than 9 months of age and less than 8 pounds, breeding, pregnant or lactating dogs, or dogs with heart disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite and tiredness.
View full product label for complete safety information or contact your veterinarian.
© 2020 Elanco or its affiliates.
Galliprant, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
PM-US-19-0323(4)
